Modern Aspects of Pharmaceutical Quality Assurance Developing & Proposing Application models, SOPs, practical audit systems for Pharma Industry /
The pharmaceutical quality system ensures that the process performance is suitably achieved, the product quality is regularly met, improved opportunities are identified and evaluated, and the knowledge is constantly expanded. Auditing also plays a crucial role within the pharmaceutical industry. It...
Uloženo v:
| Korporativní autor: | |
|---|---|
| Další autoři: | , , |
| Médium: | Elektronický zdroj E-kniha |
| Jazyk: | angličtina |
| Vydáno: |
Singapore :
Springer Nature Singapore : Imprint: Springer,
2024.
|
| Vydání: | 1st ed. 2024. |
| Témata: | |
| On-line přístup: | https://doi.org/10.1007/978-981-99-9271-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-981-99-9271-3 | ||
| 003 | DE-He213 | ||
| 005 | 20260810165958.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240311s2024 si | o |||| 0|eng d | ||
| 020 | |a 9789819992713 |9 978-981-99-9271-3 | ||
| 024 | 7 | |a 10.1007/978-981-99-9271-3 |2 doi | |
| 050 | 4 | |a RS400-431 | |
| 072 | 7 | |a PSB |2 bicssc | |
| 072 | 7 | |a SCI013040 |2 bisacsh | |
| 072 | 7 | |a PNB |2 thema | |
| 082 | 0 | 4 | |a 615.19 |2 23 |
| 245 | 1 | 0 | |a Modern Aspects of Pharmaceutical Quality Assurance |h [electronic resource] : |b Developing & Proposing Application models, SOPs, practical audit systems for Pharma Industry / |c edited by Minal Ghante, Manohar Potdar, Vidhya Bhusari. |
| 250 | |a 1st ed. 2024. | ||
| 264 | 1 | |a Singapore : |b Springer Nature Singapore : |b Imprint: Springer, |c 2024. | |
| 300 | |a 1 online resource (VIII, 523 p. 1 illus.). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a Chater 1 Introduction: Quality Assurance from Perspective of Pharmaceutical Industry -- Chapter 2 Six-sigma Model in Pharma Industry (Part-I) -- Chapter 3. Six-sigma Model in Pharma Industry (Part-II) -- Chapter 4 Developing a practical audit system for a pharmaceutical industry based on six system inspection model -- Chapter 5 -- Compliance Tools to Assist the Drug Industry for Regulatory Audits from Developed Countries -- Chapter 6 Developing an Application Model for Planning, Controlling, Improving and Assuring Quality for Pharmaceutical Industry - covering Quality Planning and Quality Control -- Chapter 7 Developing an Application model for Improving Quality for Pharmaceutical Manufacturing based on the Quality principle- covering Quality Improvement and Quality Assurance Audit -- Chapter 8 Developing a Design Qualification Protocol as Standard Operating Procedure for a Pharmaceutical Plant Facility Meeting cGMP requirement for Tablets andCapsule Manufacturing Department -- Chapter 9 Developing a Design Qualification Protocol as Standard Operating Procedure for a Pharmaceutical Plant Facility Meeting cGMP requirement for Liquid oral and Ointment Department -- Chapter 10 Developing a simplified model Standard Operating Procedure to implement quality metrics for Pharmaceutical Manufacturing System -- Chapter 11 Documentation and data integrity in Pharmaceutical Industry -- Chapter 12 Quality Risk Management. Chapter 13 Deviation, Change control and CAPA. | |
| 520 | |a The pharmaceutical quality system ensures that the process performance is suitably achieved, the product quality is regularly met, improved opportunities are identified and evaluated, and the knowledge is constantly expanded. Auditing also plays a crucial role within the pharmaceutical industry. It helps to assess and review quality to improve and build a better system for the benefit of companies. This book aims to develop a tool that will substantially decrease the number of Inspectional Observations and Warning letters, thus eliminating Import Alerts and Consent Decree. This book targets the Pharmaceutical Industry and students of Pharmaceutical Quality Assurance so they can get in hand-ready consolidated information on Pharmaceutical Quality guidelines, Quality metrics, and implementation of simplified SOP guidelines, plant layouts to implement Quality metrics for Pharmaceutical Manufacturing systems in tablets, capsules, liquid orals, and semi-solid dosage forms. The chapters cover the various aspects of Pharmaceutical Quality Assurance. The selection of topics is mainly based on the requirements of Pharmaceutical regulatory guidelines of India, the UK, the USA, Australia, and South Africa. Each chapter includes the abstract, detailed explanation, implementation guidelines, flowcharts, layouts, and Standard Operating Procedure of quality metrics for the Pharmaceutical Manufacturing System. | ||
| 532 | 8 | |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Pharmaceutical chemistry. | |
| 650 | 0 | |a Industrial policy. | |
| 650 | 0 | |a Drug delivery systems. | |
| 650 | 1 | 4 | |a Pharmaceutics. |
| 650 | 2 | 4 | |a Regulation and Industrial Policy. |
| 650 | 2 | 4 | |a Drug Delivery. |
| 700 | 1 | |a Ghante, Minal. |e editor. |0 (orcid)0000-0002-3197-150X |1 https://orcid.org/0000-0002-3197-150X |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Potdar, Manohar. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Bhusari, Vidhya. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9789819992706 |
| 776 | 0 | 8 | |i Printed edition: |z 9789819992720 |
| 776 | 0 | 8 | |i Printed edition: |z 9789819992737 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-99-9271-3 |
| 912 | |a ZDB-2-CMS | ||
| 912 | |a ZDB-2-SXC | ||
| 950 | |a Chemistry and Materials Science (SpringerNature-11644) | ||
| 950 | |a Chemistry and Material Science (R0) (SpringerNature-43709) | ||